AIMD - Ainos, Inc.
1.38
-0.090 -6.522%
Share volume: 24,707
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$1.47
-0.09
-0.06%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-13-2024 | 08-05-2024 | 11-06-2024 | 03-07-2025 | 05-14-2025 | 08-13-2025 | 11-13-2025 | |
| Total revenue | 20.729 K | 0.000 | 0.000 | 0.000 | 106.207 K | 4.663 K | 2.167 K | |
| Cost of revenue | 26.754 K | 25.373 K | 547.000 | -79.000 | 18.233 K | 937.000 | 477.000 | |
| Gross profit | -6.025 K | -25.373 K | -547.000 | 79.000 | 87.974 K | 3.726 K | 1.690 K | |
| -321.13% | 97.84% | 114.44% | 111,259.49% | -95.76% | -54.64% | |||
| Operating expenses | 3.114 M | 3.024 M | 3.038 M | 4.634 M | 3.251 M | 3.749 M | 2.786 M | |
| Selling general and admin | 1.029 M | 1.045 M | 1.016 M | 2.305 M | 1.527 M | 1.838 M | 795.253 K | |
| Research and development | 2.085 M | 1.979 M | 2.022 M | 2.328 M | 1.724 M | 1.912 M | 1.991 M | |
| Total expenses | 3.114 M | 3.024 M | 3.038 M | 4.634 M | 3.251 M | 3.749 M | 2.786 M | |
| -2.90% | 0.48% | 52.52% | -29.84% | 15.34% | -25.70% | |||
| Operating income | -3.120 M | -3.049 M | -3.039 M | -4.634 M | -3.163 M | -3.746 M | -2.784 M | |
| Ebit | -3.266 M | -3.195 M | -3.435 M | -4.350 M | -3.106 M | -3.907 M | -2.755 M | |
| Pretax income | -3.315 M | -3.195 M | -3.699 M | -4.653 M | -3.286 M | -4.085 M | -2.932 M | |
| -3.61% | 15.78% | 25.79% | -29.38% | 24.31% | -28.23% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 800.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -3.315 M | -3.195 M | -3.699 M | -4.654 M | -3.286 M | -4.085 M | -2.932 M | |
| 3.61% | -15.78% | -25.81% | 29.39% | -24.31% | 28.23% |